These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 29492663

  • 1. The striatal cholinergic system in L-dopa-induced dyskinesias.
    Perez XA, Bordia T, Quik M.
    J Neural Transm (Vienna); 2018 Aug; 125(8):1251-1262. PubMed ID: 29492663
    [Abstract] [Full Text] [Related]

  • 2. Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum.
    Aldrin-Kirk P, Heuer A, Rylander Ottosson D, Davidsson M, Mattsson B, Björklund T.
    Neurobiol Dis; 2018 Jan; 109(Pt A):148-162. PubMed ID: 29037828
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease.
    Ztaou S, Amalric M.
    Neurochem Int; 2019 Jun; 126():1-10. PubMed ID: 30825602
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cholinergic control of striatal neurons to modulate L-dopa-induced dyskinesias.
    Bordia T, Perez XA.
    Eur J Neurosci; 2019 Mar; 49(6):859-868. PubMed ID: 29923650
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enhanced histamine H2 excitation of striatal cholinergic interneurons in L-DOPA-induced dyskinesia.
    Lim SAO, Xia R, Ding Y, Won L, Ray WJ, Hitchcock SA, McGehee DS, Kang UJ.
    Neurobiol Dis; 2015 Apr; 76():67-76. PubMed ID: 25661301
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The Dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia.
    Castello J, Cortés M, Malave L, Kottmann A, Sibley DR, Friedman E, Rebholz H.
    Sci Rep; 2020 Feb 13; 10(1):2542. PubMed ID: 32054879
    [Abstract] [Full Text] [Related]

  • 16. Multiple roles for nicotine in Parkinson's disease.
    Quik M, Huang LZ, Parameswaran N, Bordia T, Campos C, Perez XA.
    Biochem Pharmacol; 2009 Oct 01; 78(7):677-85. PubMed ID: 19433069
    [Abstract] [Full Text] [Related]

  • 17. Brain α7 nicotinic acetylcholine receptors in MPTP-lesioned monkeys and parkinsonian patients.
    Morissette M, Morin N, Grégoire L, Rajput A, Rajput AH, Di Paolo T.
    Biochem Pharmacol; 2016 Jun 01; 109():62-69. PubMed ID: 27038656
    [Abstract] [Full Text] [Related]

  • 18. Loss of VGLUT3 Produces Circadian-Dependent Hyperdopaminergia and Ameliorates Motor Dysfunction and l-Dopa-Mediated Dyskinesias in a Model of Parkinson's Disease.
    Divito CB, Steece-Collier K, Case DT, Williams SP, Stancati JA, Zhi L, Rubio ME, Sortwell CE, Collier TJ, Sulzer D, Edwards RH, Zhang H, Seal RP.
    J Neurosci; 2015 Nov 11; 35(45):14983-99. PubMed ID: 26558771
    [Abstract] [Full Text] [Related]

  • 19. Striatal cholinergic transmission. Focus on nicotinic receptors' influence in striatal circuits.
    Assous M.
    Eur J Neurosci; 2021 Apr 11; 53(8):2421-2442. PubMed ID: 33529401
    [Abstract] [Full Text] [Related]

  • 20. Impact of grafted serotonin and dopamine neurons on development of L-DOPA-induced dyskinesias in parkinsonian rats is determined by the extent of dopamine neuron degeneration.
    Carlsson T, Carta M, Muñoz A, Mattsson B, Winkler C, Kirik D, Björklund A.
    Brain; 2009 Feb 11; 132(Pt 2):319-35. PubMed ID: 19039008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.